September 5, 2016
Sysmex Corporation (“Sysmex”) is headquartered in Japan and deals with the development, manufacture, sale, and distribution of diagnostic instruments, reagents and related software. It claims to be the largest supplier of hematology instrumentation and has established its branch office in the Philippines since 2000. Hyphens Pharma Pte. Ltd. (“Hyphens Pharma”) is a Singapore-based pharmaceutical company, which asserts to be the leader in specialty pharmaceuticals throughout the South East Asia region.
The dispute between Hyphens Pharma and Sysmex stemmed from Sysmex’s filing of a trademark application for the mark “HYPHEN BIOMED”, which covers goods under Class 5, namely: in vitro diagnostic and diagnostic preparations, among others. Hyphens Pharma opposed the application arguing that “HYPHEN BIOMED” is confusingly similar to its trademark and tradename “HYPHENS,” also covering goods under Class 5. On the contrary, Sysmex pointed to the presence of “BIOMED” and other device elements in the parties’ respective marks, which it claimed to sufficiently distinguish them from each other.